Christopher J. Hoimes, DO, discusses an unmet medical need in the population of patients with urothelial carcinoma.
Christopher J. Hoimes, DO, an assistant professor in the Department of Medicine Division of Hematology and Oncology at the School of Medicine and a member of the Genitourinary Malignancies Program at Case Comprehensive Cancer Center, Case Western Reserve University, discusses an unmet medical need in the population of patients with urothelial carcinoma.
Patients with urothelial carcinoma who are cisplatin-ineligible represent a population of unmet need. At this time, cisplatin-combination chemotherapy is the recommended treatment, but many patients are not eligible for this therapy. The therapeutic options for these patients are limited, as well, notes Hoimes.
Researchers Explore Novel Treatment Strategies CNS Lymphoma
March 30th 2023In an interview with Targeted Oncology, Craig Sauter, MD, discusses available treatments for patients with central nervous system lymphoma and research that will provide more developments moving forward in this space.
Read More
Expert Stresses Importance of Transportation Security to Improve Cancer Care
March 29th 2023In an interview, Krisda Chaiyachati, MD, MPH, discussed some of the social determinants of health for patients with cancer and some of the challenges patients undergoing treatment face, including transportation insecurity.
Read More
Considering Targeted Therapies When Managing Young Patients With mCRC
March 27th 2023In an interview with Targeted Oncology, Jennifer Y. Wo, MD, highlighted emerging discussions in the metastatic colorectal cancer space, where targeted therapies play a role, and what the next steps for research include.
Read More
Ruxolitinib Extended-Release Could Mitigate Risk/Increase Compliance for Patients With MPNs
March 24th 2023In an interview with Targeted Oncology, Aaron T. Gerds, MD, MS, provided an in-depth discussion on the complete response letter issued to ruxolitinib extended-release, and why continued evaluation of the agent could be beneficial for patients with MPNs.
Read More
2 Clarke Drive
Cranbury, NJ 08512